Obesity drugs Wegovy and Zepbound show high patient compliance and reduced need for other medications.
Obesity drugs Wegovy and Zepbound show promising results in patient compliance, with doctors reporting that most patients intend to take them "forever" and many stop needing other drugs. This contrasts with the general trend of patients not taking prescribed medications, leading to preventable medical costs and deaths. The blockbuster drugs have astounded the world for their effectiveness in helping people lose weight and maintain it.
March 24, 2024
5 Articles